-
Biogen Inc. is an
American multinational biotechnology company based in Cambridge, M****achusetts,
United States specializing in the discovery, development...
-
Biogen (UK) Ltd is a
leading UK
owner and
operator of
anaerobic digestion and
composting plants based in Bedfordshire. It is
responsible for the construction...
-
people with Alzheimer's
disease to
reduce its buildup. It was
developed by
Biogen and Eisai.
Aducanumab is
given via
intravenous infusion.
Aducanumab was...
- was CEO
between 2021 and 2022. He was
formerly the
president and CEO of
Biogen Idec
until he
retired effective June 8, 2010. At the same time, he started...
-
funded by Cure SMA.
Starting in 2012,
Ionis partnered with
Biogen on
development and, in 2015,
Biogen acquired an
exclusive license to the drug for a US$75...
- 2016
Biogen announced that it
would spin off its
hemophilia drug
business (Eloctate and Alprolix) into a
separate public company. In August,
Biogen announced...
-
Biologics (50 per cent plus one share) and the U.S.-based
Biogen Idec (50 per cent). In 2014,
Biogen Idec
agreed to
commercialize ****ure anti-TNF biosimilar...
-
developed by
Ionis Pharmaceuticals and was
licensed to, and co-developed by,
Biogen. The
effectiveness of
tofersen was
evaluated in a 28-w****, randomized, double-blind...
-
private equity fund
backed by
Ernesto Bertarelli and his family. He
joined Biogen as
President and
Chief Executive Officer and
member of the
Board of Directors...
-
conducted by
Fumapharm in
collaboration with
Biogen Idec;
Fumapharm was
subsequently acquired by
Biogen Idec in 2006.
Aditech Pharma in
Sweden had also...
